β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

Clinical trial NCT03123484 · UNKNOWN

Trial details

NCT number: NCT03123484
Sponsor: China Medical University, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2017-04-01
Primary completion: 2019-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.